Unroofing and curettage for recurrent sacrococcygeal pilonidal disease.

IF 1.6 4区医学 Q2 SURGERY Frontiers in Surgery Pub Date : 2024-11-20 eCollection Date: 2024-01-01 DOI:10.3389/fsurg.2024.1456846

Mehmet Ali Koc, Haydar Celasin, Kaan Sunter, Cihangir Akyol, Ibrahim Ethem Gecim

{"title":"Unroofing and curettage for recurrent sacrococcygeal pilonidal disease.","authors":"Mehmet Ali Koc, Haydar Celasin, Kaan Sunter, Cihangir Akyol, Ibrahim Ethem Gecim","doi":"10.3389/fsurg.2024.1456846","DOIUrl":null,"url":null,"abstract":"Purpose: Sacrococcygeal pilonidal disease (SPD) is a global concern, notably in Southeast Europe and the Middle East. Unroofing curettage (UC), which provides faster recovery, better cosmetic appearance, and lower recurrence rates in the primary cases, was evaluated with the results of recurrent disease.Methods: This retrospective study included 74 patients with recurrent disease who were over 16 years of age, experienced recurrence after at least one surgical attempt, and underwent unroofing curettage between 2007 and 2019. Operation time, return to work duration, and recurrence rates were assessed.Results: Mean age of patients was 29.8 ± 10.6 years, and 61 (82.4%) were male. Previous procedures included excision + flap reconstruction, excision + primary closure, and local excision + lay open. Mean operation time for unroofing curettage was 22 ± 5.3 min. Mean durations for return to work and recovery were 5.9 ± 3 days, and 6.5 ± 2.6 weeks, respectively. Mean follow-up duration was 81.6 ± 49 months. Recurrence was only observed in 1 (1.3%) patient. Unroofing curettage showed a mean recurrence-free period of 156.9 months (95% CI [, 152.9-160.9 months).Conclusion: Unroofing curettage stands out as a low-recurrence approach, likely to persist as a treatment method, especially for a selected group with recurrence.","PeriodicalId":12564,"journal":{"name":"Frontiers in Surgery","volume":"11 ","pages":"1456846"},"PeriodicalIF":1.6000,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11614795/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fsurg.2024.1456846","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Sacrococcygeal pilonidal disease (SPD) is a global concern, notably in Southeast Europe and the Middle East. Unroofing curettage (UC), which provides faster recovery, better cosmetic appearance, and lower recurrence rates in the primary cases, was evaluated with the results of recurrent disease.

Methods: This retrospective study included 74 patients with recurrent disease who were over 16 years of age, experienced recurrence after at least one surgical attempt, and underwent unroofing curettage between 2007 and 2019. Operation time, return to work duration, and recurrence rates were assessed.

Results: Mean age of patients was 29.8 ± 10.6 years, and 61 (82.4%) were male. Previous procedures included excision + flap reconstruction, excision + primary closure, and local excision + lay open. Mean operation time for unroofing curettage was 22 ± 5.3 min. Mean durations for return to work and recovery were 5.9 ± 3 days, and 6.5 ± 2.6 weeks, respectively. Mean follow-up duration was 81.6 ± 49 months. Recurrence was only observed in 1 (1.3%) patient. Unroofing curettage showed a mean recurrence-free period of 156.9 months (95% CI [, 152.9-160.9 months).

Conclusion: Unroofing curettage stands out as a low-recurrence approach, likely to persist as a treatment method, especially for a selected group with recurrence.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

复发性骶尾骨毛突病的开颅刮除术。

目的：骶尾蚴毛突病（SPD）是全球关注的问题，特别是在东南欧和中东。在原发病例中，无顶刮除（UC）提供更快的恢复，更好的外观和更低的复发率，并与复发疾病的结果进行了评估。方法：本回顾性研究包括74例复发性疾病患者，年龄超过16岁，在2007年至2019年期间至少进行过一次手术后复发，并进行了无顶刮除。评估手术时间、复工时间及复发率。结果：患者平均年龄29.8±10.6岁，男性61例（82.4%）。以前的手术包括切除+皮瓣重建，切除+初级闭合，局部切除+切开。无顶刮除平均操作时间为22±5.3 min。恢复工作和恢复的平均时间分别为5.9±3天和6.5±2.6周。平均随访时间81.6±49个月。仅有1例（1.3%）患者复发。无顶刮除的平均无复发期为156.9个月（95% CI[, 152.9-160.9个月）。结论：无顶刮除是一种低复发率的治疗方法，特别是对于复发的特定组，可能会持续存在。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Frontiers in Surgery Medicine-Surgery

CiteScore

1.90

自引率

11.10%

发文量

1872

审稿时长

12 weeks

期刊介绍： Evidence of surgical interventions go back to prehistoric times. Since then, the field of surgery has developed into a complex array of specialties and procedures, particularly with the advent of microsurgery, lasers and minimally invasive techniques. The advanced skills now required from surgeons has led to ever increasing specialization, though these still share important fundamental principles. Frontiers in Surgery is the umbrella journal representing the publication interests of all surgical specialties. It is divided into several “Specialty Sections” listed below. All these sections have their own Specialty Chief Editor, Editorial Board and homepage, but all articles carry the citation Frontiers in Surgery. Frontiers in Surgery calls upon medical professionals and scientists from all surgical specialties to publish their experimental and clinical studies in this journal. By assembling all surgical specialties, which nonetheless retain their independence, under the common umbrella of Frontiers in Surgery, a powerful publication venue is created. Since there is often overlap and common ground between the different surgical specialties, assembly of all surgical disciplines into a single journal will foster a collaborative dialogue amongst the surgical community. This means that publications, which are also of interest to other surgical specialties, will reach a wider audience and have greater impact. The aim of this multidisciplinary journal is to create a discussion and knowledge platform of advances and research findings in surgical practice today to continuously improve clinical management of patients and foster innovation in this field.